Editorial
COVID-19 as a Risk Factor For Autoimmune Skin Disease
Lisa M. Arkin, MD; John S. Barbieri, MD, MBA; Edward W. Cowen, MD, MHSc
Original Investigation
Psoriasis Risk With Immune Checkpoint Inhibitors
Sheng-Yin To, BS, RPh; Cho-Hao Lee, MD; Yi-Hsien Chen, MD; et al.
Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19
Yeon-Woo Heo, MD; Jae Joon Jeon, MD; Min Chul Ha, MD; et al.
Images in Dermatology
Madelung Disease
Hong-Hao Hu, MD; Cheng-Cheng Liu, MD; Jiu-Hong Li, MD, PhD
Earn CME credit
Research Letter
Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin Syndrome
Robin Reschke, MD; Jasmin Richter; Alexander H. Enk, MD; et al.
From JAMA This Week
Tenth International Congress on Peer Review and Scientific Publication
John P. A. Ioannidis, MD, DSc; Michael Berkwits, MD, MSCE; Annette Flanagin, RN, MA; et al
|